Aktie SMIH.U SUMMIT HEALTHCARE ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Summit Healthcare Acquisition Corp. Nasdaq

Aktien

SMIH.U

KYG8566R1285

SMIH.U

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
SUMMIT HEALTHCARE ACQUISITION CORP. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers (form 8-K)
Summit Healthcare Acquisition Corp. Announces Board Changes
Summit Healthcare Acquisition Corp. Announces Resignation of Bo Tan as Chief Executive Officer
Summit Healthcare Acquisition Corp.(NasdaqCM:SMIH) dropped from NASDAQ Composite Index
Yisheng Biopharma Co., Ltd. completed the acquisition of Summit Healthcare Acquisition Corp. from Summit Healthcare Acquisition Sponsor LLC and others in a reverse merger transaction.
Summit Healthcare Acquisition, YS Biopharma Business Combination Gets Shareholder Approval
SUMMIT HEALTHCARE ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events (form 8-K)
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
SUMMIT HEALTHCARE ACQUISITION CORP. : Other Events (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
SUMMIT HEALTHCARE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Summit Healthcare Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Bolsa de Madrid: Precaución, frágil
SUMMIT HEALTHCARE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Regulation FD Disclosure (form 8-K)
Yisheng Biopharma Co., Ltd. agreed to acquire Summit Healthcare Acquisition Corp. from Summit Healthcare Acquisition Sponsor LLC and others in a reverse merger transaction.
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Summit Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
SUMMIT HEALTHCARE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EZZF Aktie
  4. SMIH.U Aktie
  5. Nachrichten Summit Healthcare Acquisition Corp.
  6. Andere Sprachen